REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Kedrion Biopharma Gmbh (Sp. z o.o.) Oddzial W Polsce (Poland)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Pharmaceutical and Medicine Manufacturing | Pharmacies and Drug Stores | Department Stores
Full name: Kedrion Biopharma Gmbh (Sp. z o.o.) Oddzial W Polsce Profile Updated: December 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Kedrion Biopharma Gmbh (Sp. z o.o.) Oddzial W Polsce is based in Poland, with the head office in Graefelfing. The enterprise operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers industry. It was established on June 29, 2018. There was a net sales revenue increase of 158.25% reported in Kedrion Biopharma Gmbh (Sp. z o.o.) Oddzial W Polsce’s latest financial highlights for 2022. Its’ total assets recorded a growth of 8.09%. The net profit margin of Kedrion Biopharma Gmbh (Sp. z o.o.) Oddzial W Polsce decreased by 4.33% in 2022.

Headquarters
Bahnhofstrasse 96
Graefelfing; Bawaria; Postal Code: 82-166

Contact Details: Purchase the Kedrion Biopharma Gmbh (Sp. z o.o.) Oddzial W Polsce report to view the information.

Basic Information
Outstanding Shares:
Purchase the Kedrion Biopharma Gmbh (Sp. z o.o.) Oddzial W Polsce report to view the information.
Incorporation Date:
June 29, 2018
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Power of Attorney
Company Performance
Financial values in the chart are available after Kedrion Biopharma Gmbh (Sp. z o.o.) Oddzial W Polsce report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
158.25%▲
Total operating revenue
158.25%▲
Operating profit (EBIT)
27.2%▲
EBITDA
27.11%▲
Net Profit (Loss) for the Period
32.5%▲
Total assets
8.09%▲
Total equity
36.2%▲
Operating Profit Margin (ROS)
-5.53%▼
Net Profit Margin
-4.33%▼
Return on Equity (ROE)
-0.74%▼
Quick Ratio
0.76%▲
Cash Ratio
0.28%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo